SCIENTIFIC publications

/cun/en/investigacion/publicaciones-cientificas/areaMain/02
  • Pazopanib-induced asymptomatic radiological acute pancreatitis

    Baraibar I (1), Quílez A (2), Salas D (1), Román M (1), Rolfo C (3), Pérez-Gracia JL (1), Gil-Bazo I (1). (1) Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Department of Radiology, Clínica Universidad de Navarra, Pamplona, Spain.
    (3) Phase I - Early Clinical Trials Unit, Antwerp University Hospital, Edegem, Belgium.

    Molecular and Clinical Oncology 22 MAY 2017

  • Effects of diets on adipose tissue

    Ezquerro S (1), Rodríguez A (1), Portincasa P (2), Frühbeck G (1). (1) Metabolic Research Laboratory, Clínica Universidad de Navarra, IdiSNA, Pamplona. Spain.
    (2) Clinica Medica "A. Murri", Department of Biomedical Sciences and Human Oncology University of Bari Medical School, Policlinico Hospital, Bari. Italy.

    Current Medicinal Chemistry 17 MAY 2017

  • Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone

    Moreau P (1), Dimopoulos MA (2), Richardson PG (3), Siegel DS (4), Cavo M (5), Corradini P (6), Weisel K (7), Delforge M (8), O'Gorman P (9), Song K (10), Chen C (11), Bahlis N (12), Oriol A (13), Hansson M (14), Kaiser M (15), Anttila P (16), Raymakers R (17), Joao C (18), Cook G (19), Sternas L (20), Biyukov T (21), Slaughter A (21), Hong K (20), Herring J (20), Yu X (20), Zaki M (20), San-Miguel J (22). (1) University Hospital Hôtel-Dieu, Nantes, France.
    (2) National and Kapodistrian University of Athens, Athens, Greece.
    (3) Dana-Farber Cancer Institute, Boston, MA, USA.
    (4) John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
    (5) Bologna University School of Medicine, Bologna, Italy.
    (6) University of Milano, Fondazione IRCCS Istituto Nazionale de Tumori, Milano, Italy.
    (7) University Hospital of Tuebingen, Tuebingen, Germany.
    (8) University Hospital Leuven, Leuven, Belgium.
    (9) Mater Misericordiae University Hospital, University College Dublin, Dublin, Ireland.
    (10) Vancouver General Hospital, Vancouver, British Columbia, Canada.
    (11) Princess Margaret Hospital, Toronto, Ontario, Canada.
    (12) Tom Baker Cancer Center-University of Calgary, Calgary, Canada.
    (13) Institut Català d'Oncologia, Institut Josep Carreras. Hospital Germans Trias i Pujol, Barcelona, Spain.
    (14) Skane University Hospital, Lund University, Lund, Sweden.
    (15) The Royal Marsden Hospital, Surrey, UK.
    (16) Helsinki University and Helsinki University Hospital Comprehensive Cancer, Helsinki, Finland.
    (17) University Medical Center Utrecht, Utrecht, The Netherlands.
    (18) Hemato-Oncology Department, Champalimaud Foundation for the Unknown and Faculdade de Ciências Médicas-NOVA University, Lisbon, Portugal.
    (19) St James's Institute of Oncology, St James's University Hospital, Leeds, UK.
    (20) Celgene Corporation, Summit, NJ, USA.
    (21) Celgene International Sàrl, Boudry, Switzerland.
    (22) Clinica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain.

    European Journal of Haematology 15 MAY 2017

  • Differences between GesEPOC and GOLD in 2017

    de-Torres JP (1), Marin JM (2). (1) Servicio de Neumología, Clínica Universidad de Navarra, Pamplona,España.
    (2) Servicio de Neumología, Hospital Universitario Miguel Servet, Zaragoza, España.

    Archivos de Bronconeumología 13 MAY 2017

  • A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

    Inogés S (1,2), Tejada S (3), de Cerio AL (4,5), Pérez-Larraya JG (6), Espinós J (7), Idoate MA (8), Domínguez PD (9), de Eulate RG (9), Aristu J (10), Bendandi M (11,12), Pastor F (13), Alonso M (14), Andreu E (5), Cardoso FP (4,15), Valle RD (16). (1) Cell Therapy Area, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
    (2) Immunology and Immunotherapy Department, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
    (3) Neurosurgery Department, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
    (4) Cell Therapy Area, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
    (5) Immunology and Immunotherapy Department, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
    (6) Neurology Department, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
    (7) Oncology Department, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
    (8) Pathology Department, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
    (9) Radiology Department, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
    (10) Radiation Oncology Department, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
    (11) Section on Hematology/Oncology, Department of Internal Medicine, Comprehensive Cancer Center, Wake Forest University Baptist Healthcare Center, Winston-Salem, NC, USA.
    (12) Section of Hematology/Oncology, Department of Internal Medicine, W.G Hefner VA Medical Center, Salisbury/Charlotte, NC, USA.
    (13) Program of Molecular Therapies, Aptamer Unit, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Avenida Pio XII 55, 31008, Pamplona, Navarra, Spain.
    (14) Program in Solid Tumors and Biomarkers, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Avenida Pio XII 55, 31008, Pamplona, Navarra, Spain.
    (15) Haematology and Haemotherapy Department, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
    (16) Neurosurgery Department, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain

    Journal of Transational Medicine 12 MAY 2017

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra